Gene Therapy Potentially Curative for β-Thalassemia
FRIDAY, March 11, 2022 (HealthDay News) -- A one-time infusion of betibeglogene autotemcel (beti-cel) gene therapy yields high levels of transfusion independence in children and adults with transfusion-dependent β-thalassemia and a non-β0/β0 genotype, according to a study published in the Feb. 3 issue of the New England Journal of Medicine.
Franco Locatelli, M.D., Ph.D., from the University of Rome, and colleagues conducted an open-label phase 3 study to examine the efficacy and safety of beti-cel in adult and pediatric populations with transfusion-dependent β-thalassemia and a non-β0/β0 genotype. Twenty-three patients were enrolled, underwent myeloablation with busulfan, and then received intravenous beti-cel. Patients were followed for a median of 29.5 months.
The researchers found that 20 of the 22 patients (91 percent) who could be evaluated had transfusion independence, including six of seven (86 percent) who were younger than 12 years. During transfusion independence, the average hemoglobin level was 11.7 g/dL. In patients with transfusion independence, the median level of gene therapy-derived adult hemoglobin with a T87Q amino acid substitution was 8.7 g/dL at 12 months after beti-cel infusion. Four patients had at least one adverse event considered to be related or possibly related to beti-cel; all except one were nonserious. There were no cases of cancer.
"These data suggest that in most patients with transfusion-dependent β-thalassemia and a non-β0/β0 genotype, one-time infusion of beti-cel is potentially curative through transfusion independence and the attainment of near normal hemoglobin levels," the authors write.
Several authors disclosed financial ties to biopharmaceutical companies, including Bluebird Bio, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Vinculan el nacimiento prematuro con un mayor riesgo de TDAH
MARTES, 16 de agosto de 2022 (HealthDay News) -- Los niños que nacen un poco...
¿Podrían los ácidos grasos omega 3 combatir al acné?
MIÉRCOLES, 18 de mayo de 2022 (HealthDay News) -- Hasta 50 millones de...
Idiopathic CD4 Lymphocytopenia Linked to Opportunistic Infection, Cancer
THURSDAY, May 4, 2023 (HealthDay News) -- Idiopathic CD4 lymphocytopenia (ICL)...
Breast Density Varies in Racial/Ethnic Groups After BMI Adjustment
WEDNESDAY, June 14, 2023 (HealthDay News) -- After adjustment for body mass...